全文获取类型
收费全文 | 136420篇 |
免费 | 7587篇 |
国内免费 | 2610篇 |
专业分类
耳鼻咽喉 | 574篇 |
儿科学 | 2484篇 |
妇产科学 | 1456篇 |
基础医学 | 14115篇 |
口腔科学 | 3937篇 |
临床医学 | 15511篇 |
内科学 | 23877篇 |
皮肤病学 | 1760篇 |
神经病学 | 8621篇 |
特种医学 | 4414篇 |
外国民族医学 | 5篇 |
外科学 | 17424篇 |
综合类 | 16372篇 |
现状与发展 | 7篇 |
一般理论 | 5篇 |
预防医学 | 9681篇 |
眼科学 | 1861篇 |
药学 | 11032篇 |
92篇 | |
中国医学 | 9759篇 |
肿瘤学 | 3630篇 |
出版年
2023年 | 1540篇 |
2022年 | 2621篇 |
2021年 | 4609篇 |
2020年 | 3724篇 |
2019年 | 7114篇 |
2018年 | 7316篇 |
2017年 | 5578篇 |
2016年 | 3239篇 |
2015年 | 3211篇 |
2014年 | 6028篇 |
2013年 | 6408篇 |
2012年 | 5222篇 |
2011年 | 5692篇 |
2010年 | 4623篇 |
2009年 | 4038篇 |
2008年 | 4121篇 |
2007年 | 4262篇 |
2006年 | 3846篇 |
2005年 | 3430篇 |
2004年 | 3041篇 |
2003年 | 2857篇 |
2002年 | 2420篇 |
2001年 | 2384篇 |
2000年 | 1928篇 |
1999年 | 1730篇 |
1998年 | 1466篇 |
1997年 | 1560篇 |
1996年 | 1256篇 |
1995年 | 1269篇 |
1994年 | 1170篇 |
1993年 | 902篇 |
1992年 | 887篇 |
1991年 | 783篇 |
1990年 | 602篇 |
1989年 | 589篇 |
1988年 | 574篇 |
1987年 | 482篇 |
1985年 | 3374篇 |
1984年 | 3829篇 |
1983年 | 3147篇 |
1982年 | 3737篇 |
1981年 | 3326篇 |
1980年 | 2779篇 |
1979年 | 2695篇 |
1978年 | 2223篇 |
1977年 | 1682篇 |
1976年 | 2130篇 |
1975年 | 1579篇 |
1974年 | 1370篇 |
1973年 | 1317篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
目的 分析乌司他丁与连续性血液净化联用对热射病患者所产生的影响。方法 选取2017年5月—2019年2月在海南医学院第二附属医院进行治疗的88例热射病患者作为研究对象,将其分为研究组和常规组,常规组患者接受常规治疗,研究组患者在常规治疗基础上,将乌司他丁与连续性血液净化联用。分析两种治疗措施的效果。结果 治疗前两组患者的IL-17、TNF-α、cTnⅠ、β2-MG、PT、D-D、ET和TM水平,差异无统计学意义(P>0.05)。经治疗两组患者的上述指标水平都表现出下降的趋势,相对于常规组,研究组患者下降水平更明显,差异具有统计学意义(P<0.05)。研究组治疗的总有效率为95.5%,高于常规组的72.7%,差异具有统计学意义(P<0.05)。结论 运用乌司他丁与连续性血液净化联用的疗法对热射病患者进行治疗,可获得十分理想的治疗效果,可在临床工作中推广。 相似文献
32.
《Injury》2019,50(5):1105-1110
IntroductionGetting the right patient, to the right place, at the right time is dependent on a multitude of modifiable and non-modifiable factors. One potentially modifiable factor is the number and location of trauma centres (TC). Overabundance of TC dilutes volumes and could be associated with worse outcomes. We describe a methodology that evaluates trauma system reconfiguration without reductions in potential access to care. We used the mature trauma system of New South Wales (NSW) as a model given the perceived overabundance of urban major trauma centres (MTC).MethodsWe first evaluated potential access to TC care via ground and air transport through the use of geographic information systems (GIS) network analysis. Potential access was defined as the proportion of the population living within 60-min transport time from a potential scene of injury to a TC by ground or rotary-wing aircraft. Sensitivity analyses were carried out in order to account for potential pre-hospital interventions and/or transport delays; travel times of 15-, 30-, 45-, 60-, and 90-min were also analyzed. We then evaluated if the current configuration of the system (number of urban MTS in the Sydney basin) could be optimized without reductions in potential access to care using two GIS methodologies: location-allocation and individual removal of MTC.Results86% of the NSW population has potential access to a TC within 60 min ground travel time; potential access improves to 99% with rotary-wing transport. The 1% of the population without potential TC access lives in 48% of the land area (>384,000km2). Utilizing two different methodologies we identified that there was no change in potential access by ground transport after removing 1 or 2 MTC in the Sydney basin at the 30-, 45-, and 60-min transport times. However, 0.02% and 0.5% of the population would not have potential access to MTC care at 15 min after removing one and two MTC respectively.DiscussionRedistribution of the number of MTC in the Sydney basin could be achieved without a significant impact on potential access to care. Our approach can be utilized as an initial tool to evaluate a trauma system where overabundance of coverage is present. 相似文献
33.
34.
35.
《Clinical Lymphoma, Myeloma & Leukemia》2022,22(8):608-617
BackgroundConsiderable progress has been made in therapeutic options for multiple myeloma (MM). Understanding the current landscape of MM treatment options and associated outcomes in the real world is important in providing key insights into clinical and knowledge gaps which could be targeted for further optimization.MethodsThe Canadian Myeloma Research Group Database (CMRG-DB) is a prospectively maintained disease-specific database with >7000 patients. The objective of this study was to describe the trends in the treatment landscape and outcomes including early mortality, time to next treatment, and overall survival (OS) in each line of treatment stratified by autologous stem cell transplant (ASCT) receipt among newly-diagnosed MM patients in Canada between 2007 and 2018.ResultsA total of 5154 patients were identified among which 3030 patients (58.8%) received an upfront ASCT and 2124 (41.2%) did not. At diagnosis, the median age was 64 years and 58.6% were males. Bortezomib and lenalidomide were most frequently used (>50%) in first and second-line treatment respectively among both the ASCT and non-ASCT cohort. The median OS was 122.0 months (95% Cl 115.0-135.0 months) and 54.3 months (95% CI 50.8-58.8 months) for the ASCT and non-ASCT cohort respectively with an incremental decrease in OS in each subsequent line of treatment.ConclusionWe present the largest study to date in the Canadian landscape showing the characteristics, therapy usage, and outcomes among MM patients. This information will be critical in benchmarking current outcomes and provide key insight into areas of unmet needs and gaps for improvement of MM patients nationally. 相似文献
36.
Bernard Natukunda Grace Ndeezi Lay See Er Francis Bajunirwe Gayle Teramura Meghan Delaney 《ISBT科学丛刊》2019,14(4):366-373
37.
38.
39.
Frédéric Janvier Deborah Delaune Thomas Poyot Eric Valade Audrey Mérens Pierre E. Rollin Vincent Foissaud 《Emerging infectious diseases》2016,22(2):292-294
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa’s environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly. 相似文献
40.
《Cor et vasa》2015,57(3):e157-e162
IntroductionObstructive sleep apnea (OSA) is often connected with arterial hypertension and it could also be a cause of secondary hypertension. Treatment of arterial hypertension and optimal blood pressure level are important for prevention of cardiovascular complications. It is not well known how to treat patients with OSA and arterial hypertension. Also many patients with OSA suffer from metabolic syndrome which worsen their prognosis.AimThe aim of our study was to assess arterial hypertension compensation in patients with metabolic syndrome and moderate to severe OSA and to analyze used pharmacotherapy.Materials and methods85 hypertensive patients (75 men) with metabolic syndrome, average age 53.6 ± 9.3 years, were evaluated using overnight sleep study with diagnosis of OSA, average apnea–hypopnea index (AHI) 56.3 ± 23. Patients underwent 24 h ambulatory blood pressure monitoring (ABPM) and their current pharmacotherapy data were obtained. Appropriate combinations of antihypertensive drugs (patients with metabolic syndrome) were derived from ESH/ESC 2013 guidelines.ResultsArterial hypertension was well compensated in only 11.8% of the patients. 24.7% patients were treated according to current guidelines. Fisher's exact test with analysis of adjusted residues has found higher rate of blood pressure subcompensation in patients treated with triple+ combination of drugs (p = 0.035, 51.4% vs 10%).ConclusionOnly a small number of patients had optimal blood pressure level and were treated according to current ESH/ESC guidelines. We have to constantly appeal to all physicians to perform ABPM in patients with OSA. 相似文献